Mode
Text Size
Log in / Sign up
N/A Completed N=31 Randomized Single-blind Treatment

Wearable Robotic System and Robotic Mirror Therapy in Spastic Hemiplegia Post Botulinum Toxin Injection

Hemiplegia, Spastic · Spastic
Source: ClinicalTrials.gov NCT04826900 ↗
Enrolled (actual)
31
Serious AEs
Results posted
Jun 2023
Primary outcomePrimary: Fugl-Meyer Assessment (FMA) — 3; 6 score on a scale

Summary

The purpose of this project is to examine and compare the immediate and long-term effects of combined Botulinum toxin type A(BoNT-A) injection with wearable robotic hand system (RT) and Robotic mirror therapy (RMT) in patients with spastic hemiplegic stroke.

Outcome Measures

OutcomeResultp-value
PRIMARY
Fugl-Meyer Assessment (FMA)
3; 6
PRIMARY
Medical Research Council Scale (MRC)
0.30; 0.35; 0.17; 0.17; 0.25; 0.50
PRIMARY
Modified Ashworth Scale (MAS)
-0.33; -0.17; -0.42; -0.17; -0.25; 0.00
PRIMARY
Box and Block Test (BBT)
0; 0
PRIMARY
Motor Activity Log (MAL) - Amount of Use Scale (AOU)
0.14; 0.34
PRIMARY
Motor Activity Log (MAL) - Quality of Movement Scale (QOM)
0.15; 0.21

Eligibility Criteria

Inclusion Criteria

  • Clinical and imagine diagnosis of a first or recurrent unilateral stroke ≥ 3 months
  • Finger flexor muscles spasticity (modified Ashworth scale of ≥ 1+)
  • Initial motor part of UE of FMA score ranging from 10 to 56 indicating moderate to severe movement impairment
  • No serious cognitive impairment (i.e., Mini Mental State Exam score > 20)
  • Age ≥ 20 years

Exclusion Criteria

  • Pregnant
  • With bilateral hemispheric or cerebellar lesions
  • Sever aphasia
  • Significant visual field deficits or hemineglect
  • Contraindication for BoNT-A injection
  • Treatment with BoNT-A within 6 months before recruitment
  • Any fixed joint contracture of the affected upper limb
  • A history of orthopedic or other neurological diseases and/or medical conditions that would prevent adherence to the rehabilitation protocol
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04826900). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search